MA&P strategy report

Summary
The market access and pricing strategy for the vaccines developed by HIPRA will be described in this report including the potential risks and markets for the commercialisation with a clear OH strategy
More information & hyperlinks
Web resources: https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5f8c29247&appId=PPGMS
Search
Search on Google
Search on Bing
Search on DuckDuckGo
Associated projects
Organisations
  • Not specified
Powered by Chris Decubber BV